Importer of Controlled Substances Registration, 45612 [2017-20943]

Download as PDF 45612 Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices Drug Enforcement Administration Administration as importers of various classes of schedule I or II controlled substances. [Docket No. DEA–392] SUPPLEMENTARY INFORMATION: 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on February 27, 2017 (82 FR 11942). DEPARTMENT OF JUSTICE Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. Importer of Controlled Substances Registration [FR Doc. 2017–20880 Filed 9–28–17; 8:45 am] ACTION: BILLING CODE P SUMMARY: Notice of registration. Registrants listed below have applied for and been granted registration by the Drug Enforcement Company FR docket United States Pharmacopeial. Convention ................................................................................. AMRI Rensselaer, Inc ................................................................ R & D Systems, Inc ................................................................... Sigma-Aldrich International. GMBH ........................................................................................ Cambrex High Point, Inc ........................................................... The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons. Dated: September 21, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–20943 Filed 9–28–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE asabaliauskas on DSKBBXCHB2PROD with NOTICES Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Cody Laboratories, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and DATES: VerDate Sep<11>2014 18:50 Sep 28, 2017 Jkt 241001 The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. 82 FR 34694 ............................................................................ 82 FR 34696 ............................................................................ 82 FR 35546 ............................................................................ July 26, 2017. July 26, 2017. July 31, 2017. 82 FR 35547 ............................................................................ 82 FR 35992 ............................................................................ July 31, 2017. August 2, 2017. applicants therefor, may file written comments on or objections to the issuance of the proposed registration on or before October 30, 2017. Such persons may also file a written request for a hearing on the application on or before October 30, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (January 25, 2007). SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been PO 00000 Frm 00038 Published Fmt 4703 Sfmt 9990 redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on June 16, 2017, Cody Laboratories, Inc., Steve Hartman, 601 Yellowstone Avenue, Cody, Wyoming 82414–9321 applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance Phenylacetone .............. Poppy Straw Concentrate. Tapentadol .................... Drug code Schedule 8501 9670 II II 9780 II The company plans to import narcotic raw materials to manufacture bulk controlled substances for distribution to its customers. The company plans to import an intermediate form of tapentadol (9870), to bulk manufacture tapentadol for distribution to its customers. Dated: September 21, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–20942 Filed 9–28–17; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\29SEN1.SGM 29SEN1

Agencies

[Federal Register Volume 82, Number 188 (Friday, September 29, 2017)]
[Notices]
[Page 45612]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20943]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration as importers of 
various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as importers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted and no 
requests for hearing were submitted for these notices.

------------------------------------------------------------------------
           Company                  FR docket             Published
------------------------------------------------------------------------
United States Pharmacopeial.
Convention..................  82 FR 34694.........  July 26, 2017.
AMRI Rensselaer, Inc........  82 FR 34696.........  July 26, 2017.
R & D Systems, Inc..........  82 FR 35546.........  July 31, 2017.
Sigma-Aldrich International.
GMBH........................  82 FR 35547.........  July 31, 2017.
Cambrex High Point, Inc.....  82 FR 35992.........  August 2, 2017.
------------------------------------------------------------------------

    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the 
registration of the listed registrants to import the applicable basic 
classes of schedule I or II controlled substances is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated each company's maintenance of effective 
controls against diversion by inspecting and testing each company's 
physical security systems, verifying each company's compliance with 
state and local laws, and reviewing each company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I or II controlled substances to the above 
listed persons.

    Dated: September 21, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-20943 Filed 9-28-17; 8:45 am]
BILLING CODE 4410-09-P